Building confidence at the edge through embedded trust anchors

Tern plc

As digital infrastructure expands across sectors such as healthcare, energy, and manufacturing, the cost of weak or default identities is no longer theoretical. Every unverified connection introduces potential disruption, regulatory risk, and in the most critical environments, threats to safety itself.

Device Authority has placed this foundational challenge at the centre of its Zero Trust strategy. Through its KeyScaler® platform, the company has redefined how identity and policy can be embedded at the edge, directly within the manufacturing and onboarding stages of connected devices. By automating the creation of strong, unique identities tied to secure hardware or generated dynamically where hardware roots of trust do not exist, the system removes the manual processes that often lead to configuration errors and scalability issues. This enables manufacturers and operators to secure fleets of devices from the instant they connect, without human intervention or bottlenecks.

When partnered with Olympus, KeyScaler allows trust anchors to feed directly into enterprise identity and access management systems, ensuring that every device remains under continuous policy governance. Context, behaviour, and health signals can trigger automated responses, from restricted access to complete revocation, ensuring that any anomaly is addressed instantly and proportionately.

Importantly, Device Authority’s approach also acknowledges industrial reality. Many enterprises must work with extensive brownfield environments where legacy assets lack the modern security hardware of new devices. For these cases, KeyScaler’s Dynamic Device Key Generation and Trust on First Use models create strong, software-based identities that can later be reinforced through re-enrolment or attestation.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Talking Medicines builds its AI strategy around specialist life sciences intelligence

Talking Medicines is positioning specialist healthcare intelligence as the core layer that gives agentic AI useful context in life sciences.

Device Authority targets cyber resilience opportunity at TechWorks Summit 2026

Device Authority will focus on continuous IoT and OT compliance, AI and quantum risk at TechWorks Summit 2026 as it strengthens its position in connected-device security.

Talking Medicines builds a more defensible AI model for life sciences

Talking Medicines is combining proprietary healthcare intelligence, AI agents and orchestration to build a more specialised AI platform for life sciences.

Search